AXA Framlington Biotech Fund

The AXA Framlington Biotech Fund is an incredible fund that invests in the health and bio tech sector.

[http://retail.axa-im.co.uk/funds/axa-framlington/axa-framlington-biotech-fund-r-gbp-413/performance]

Year on year performance is amazing.

The Top Ten Holdings are:-

Gilead Sciences
Celgene
Amgen
Biogen Idec
Vertex Pharmaceuticals
Illumina
Alexion Pharmaceuticals
BioMarin Pharmaceutical
Salix Pharmaceuticals
Incyte USA

Today the fund is worth £360m

Leave a Reply

Your email address will not be published. Required fields are marked *